Scholarlink

<p>The digestive enzyme trypsin is an important driver of pancreatitis development and progression. Inhibition of intrapancreatic trypsin activity is an attractive yet so far unsuccessful approach for the treatment and prevention of pancreatitis. Gene therapy using adeno-associated viral vector containing the human serine protease inhibitor Kazal type 1 (<i>SPINK1</i>) gene has shown efficacy against murine pancreatitis in preclinical experiments. To advance this method to clinical testing, viral vectors with improved inhibitor expression are needed. In this study, we investigated the effect of minigenes with single introns on the expression of the mouse <i>Spink1</i> gene. We found that minigenes markedly stimulated the expression of mouse <i>Spink1</i> mRNA and SPINK1 protein in HEK 293T cells transfected with plasmids and in AR42J rat pancreatic acinar cells and isolated mouse pancreatic acini transduced with adenoviral vectors. The optimal intron size for expression enhancement was 100 nucleotides. We also demonstrated that mouse <i>Spink1</i> mRNA expressed from a cDNA construct underwent spurious mRNA splicing and minigenes prevented this splicing defect. However, enhancement of mouse <i>Spink1</i> expression by minigenes was unrelated to the rescue of aberrant mRNA splicing. The observations will facilitate the development of advanced viral vectors harboring mouse <i>Spink1</i> for preclinical therapeutic studies in mouse models of pancreatitis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Minigenes enhance heterologous expression and prevent aberrant splicing of mouse Spink1

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月2日

查看全文
  • Gergő Berke,
  • Miklós Sahin-Tóth

摘要

The digestive enzyme trypsin is an important driver of pancreatitis development and progression. Inhibition of intrapancreatic trypsin activity is an attractive yet so far unsuccessful approach for the treatment and prevention of pancreatitis. Gene therapy using adeno-associated viral vector containing the human serine protease inhibitor Kazal type 1 (SPINK1) gene has shown efficacy against murine pancreatitis in preclinical experiments. To advance this method to clinical testing, viral vectors with improved inhibitor expression are needed. In this study, we investigated the effect of minigenes with single introns on the expression of the mouse Spink1 gene. We found that minigenes markedly stimulated the expression of mouse Spink1 mRNA and SPINK1 protein in HEK 293T cells transfected with plasmids and in AR42J rat pancreatic acinar cells and isolated mouse pancreatic acini transduced with adenoviral vectors. The optimal intron size for expression enhancement was 100 nucleotides. We also demonstrated that mouse Spink1 mRNA expressed from a cDNA construct underwent spurious mRNA splicing and minigenes prevented this splicing defect. However, enhancement of mouse Spink1 expression by minigenes was unrelated to the rescue of aberrant mRNA splicing. The observations will facilitate the development of advanced viral vectors harboring mouse Spink1 for preclinical therapeutic studies in mouse models of pancreatitis.